Cargando…
Inhibitors of Protein Glycosylation Are Active against the Coronavirus Severe Acute Respiratory Syndrome Coronavirus SARS-CoV-2
Repurposing clinically available drugs to treat the new coronavirus disease 2019 (COVID-19) is an urgent need in the course of the Severe Acute Respiratory Syndrome coronavirus (SARS-CoV-2) pandemic, as very few treatment options are available. The iminosugar Miglustat is a well-characterized drug f...
Autores principales: | Rajasekharan, Sreejith, Milan Bonotto, Rafaela, Nascimento Alves, Lais, Kazungu, Yvette, Poggianella, Monica, Martinez-Orellana, Pamela, Skoko, Natasa, Polez, Sulena, Marcello, Alessandro |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8144969/ https://www.ncbi.nlm.nih.gov/pubmed/33946304 http://dx.doi.org/10.3390/v13050808 |
Ejemplares similares
-
Expression, purification and characterization of SARS-CoV-2 spike RBD in ExpiCHO cells
por: De March, Matteo, et al.
Publicado: (2022) -
A Simplified and Efficient Process for Insulin Production in Pichia pastoris
por: Polez, Sulena, et al.
Publicado: (2016) -
The cholesterol metabolite 27-hydroxycholesterol inhibits SARS-CoV-2 and is markedly decreased in COVID-19 patients
por: Marcello, Alessandro, et al.
Publicado: (2020) -
Application of simple fed-batch technique to high-level secretory production of insulin precursor using Pichia pastoris with subsequent purification and conversion to human insulin
por: Gurramkonda, Chandrasekhar, et al.
Publicado: (2010) -
Cathepsin inhibitors nitroxoline and its derivatives inhibit SARS-CoV-2 infection
por: Milan Bonotto, Rafaela, et al.
Publicado: (2023)